Hemolytic-uremic syndrome

Jump to: navigation, search

For patient information click here

Hemolytic-uremic syndrome
ICD-10 D59.3
ICD-9 283.11
OMIM 235400
DiseasesDB 13052
MedlinePlus 000510
MeSH D006463

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome

CDC on Hemolytic-uremic syndrome

Hemolytic-uremic syndrome in the news

Blogs on Hemolytic-uremic syndrome

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Synonyms and Keywords:

Overview

Classification

Pathophysiology

  • shiga toxin–induced

endothelial cytotoxicity in the hemolytic uremic syndrome after infection with shiga toxin–producing Escherichia coli or other microorganisms. Thrombotic microangiopathy can also occur in patients with pneumococcal sepsis and less commonly other infections in which microbial neuraminidases expose the Thomsen-Friedenreich antigen on endothelial and red cells, subjecting the cells to attack by preexisting antibodies against the antigen

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Hemolytic uremic syndrome occurs one to three cases per 100,000 children in children one to 10 years of age annually.

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention |Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related chapters


de:Hämolytisch-urämisches Syndrom no:Hemolytisk-uremisk syndrom nn:Hemolytisk uremisk syndrom sr:Хемолитички уремијски синдром


Linked-in.jpg